Release Date: 24/11/15 09:07 Summary: Board and Company Secretary Changes Price Sensitive: Yes Download Document 162.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%